bicalutamide has been researched along with Carcinoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Hu, X; Liu, Z; Lv, R; Meng, L; Yan, L; Zhang, Y | 1 |
| Jeong, ISD; Moyers, J; Thinn, MM; Thung, I | 1 |
| Gourd, E | 1 |
| Cai, S; Chen, H; Chen, K; Chen, R; Guo, S; Hu, Z; Ji, JY; Li, M; Li, W; Liu, J; Liu, X; Liu, Z; Wang, C; Wang, L; Wang, T; Wu, K; Wu, L; Xu, H; Xu, S; Yang, J; Ye, Z; Zhuang, Q | 1 |
| Chang, MD; Davidson, AJ; De Fontgalland, D; Johnson, D; Sutherland, T; Wong, LM | 1 |
| Baron, B; Chowdhury, S; Heidenreich, A; Holmstrom, S; Ivanescu, C; Klotz, L; Lin, P; Shore, ND; Siemens, DR; Villers, A; Wang, F | 1 |
| Matousek, RH; Sherwin, BB | 1 |
| Itoh, K; Kanayama, H; Kawabata, R; Oie, S; Oka, T; Takahashi, M | 1 |
| Kakehi, Y; Kato, T; Kazuki, N; Kushida, Y; Kuwata, Y; Matsuoka, Y; Taoka, T; Yamamoto, N | 1 |
| Lee, EC; Packman, K; Schallhom, R; Tenniswood, M; Zhan, P | 1 |
| Huang, W; Iczkowski, KA; Mazzucchelli, R; Montironi, R; Pantazis, CG; Stevens, GR | 1 |
| Brown, SC; Collins, GN; Manikandan, R; O'Reilly, P; Pearson, E; Srirangam, SJ | 1 |
| Augustin, H; Bayer, L; Freibauer, C; Kuber, W; Lunglmayr, G; Pummer, K; Tschurlovich, F | 1 |
| Armstrong, J; Delaere, K; Hetherington, J; Heyns, CF; Navani, S; Pina, F; Ramon, J; Sánchez-Chapado, M; Tyrrell, C; Wallace, DM; Wirth, M | 1 |
| Bologna, M; Festuccia, C; Gravina, GL; Muzi, P; Pomante, R; Ricevuto, E; Ventura, L; Vicentini, C | 1 |
| Beacock, C; Debruyne, F; Kaisary, AV; Lunglmayr, G; Tyrrell, CJ | 1 |
| Erman, M; Ruacan, S; Tekuzman, G; Yalçin, S | 1 |
6 trial(s) available for bicalutamide and Carcinoma
| Article | Year |
|---|---|
Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial.
Topics: Anilides; Antineoplastic Agents; Benzamides; Cancer Pain; Carcinoma; Double-Blind Method; Humans; Male; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Tosyl Compounds; Treatment Outcome | 2017 |
A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cognition; Drug Administration Schedule; Estradiol; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neuropsychological Tests; Nitriles; Placebos; Prostatic Neoplasms; Tosyl Compounds | 2010 |
Diethylstilboestrol versus bicalutamide in hormone refractory prostate carcinoma: a prospective randomized trial.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma; Diethylstilbestrol; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2005 |
Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma; Cell Proliferation; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Prognosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Withholding Treatment | 2006 |
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.
Topics: Anilides; Antineoplastic Agents; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Double-Blind Method; Follow-Up Studies; Humans; Male; Nitriles; Placebos; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2007 |
A randomised comparison of monotherapy with Casodex 50 mg daily and castration in the treatment of metastatic prostate carcinoma. Casodex Study Group.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Humans; Male; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds; Treatment Failure | 1995 |
11 other study(ies) available for bicalutamide and Carcinoma
| Article | Year |
|---|---|
Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma.
Topics: Anilides; Carcinoma; Docetaxel; Humans; Male; Nitriles; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Retrospective Studies; Tosyl Compounds; Vascular Endothelial Growth Factor A | 2022 |
Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma.
Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Humans; Leuprolide; Male; Nitriles; Paclitaxel; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds | 2020 |
Combined androgen blockade for salivary gland carcinoma.
Topics: Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials, Phase II as Topic; Disease-Free Survival; Humans; Leuprolide; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Signal Transduction; Tosyl Compounds; Treatment Outcome | 2018 |
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carcinogenesis; Carcinoma; Cell Growth Processes; Drug Resistance; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oncogene Protein v-akt; Prostatic Neoplasms; Proteins; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Survival Analysis; Tosyl Compounds; Tumor Cells, Cultured | 2014 |
Unusual presentation of advanced prostate cancer masquerading as metastatic and obstructing rectosigmoid cancer.
Topics: Abdomen; Aged, 80 and over; Androgen Antagonists; Anilides; Carcinoma; Fatal Outcome; Humans; Intestinal Obstruction; Laparotomy; Male; Nitriles; Prostatic Neoplasms; Rectal Neoplasms; Sigmoid Neoplasms; Tomography Scanners, X-Ray Computed; Tosyl Compounds | 2017 |
Hydroxyflutamide enhances cellular sensitivity to 5-fluorouracil by suppressing thymidylate synthase expression in bicalutamide-resistant human prostate cancer cells.
Topics: Androgen Antagonists; Anilides; Antimetabolites, Antineoplastic; Carcinoma; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Flutamide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Models, Biological; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Thymidylate Synthase; Tosyl Compounds | 2011 |
[Disseminated carcinomatosis of the bone marrow in two patients with prostate cancer].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Bone Marrow Neoplasms; Carcinoma; Diphosphonates; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fatal Outcome; Humans; Imidazoles; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome; Zoledronic Acid | 2011 |
Antiandrogen-induced cell death in LNCaP human prostate cancer cells.
Topics: Androgen Antagonists; Anilides; bcl-2-Associated X Protein; Carcinoma; Caspases; Cell Adhesion; Cell Death; Cell Nucleus; Cell Survival; Cytochromes c; Humans; Male; Membrane Potentials; Mitochondria; Nitriles; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tosyl Compounds; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2003 |
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Carcinoma; Catalytic Domain; Goserelin; Humans; Immunohistochemistry; Male; Middle Aged; Nitriles; Peptide Fragments; Prostatectomy; Prostatic Neoplasms; Telomerase; Tosyl Compounds | 2004 |
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Blotting, Western; Carbazoles; Carcinoma; Cell Line, Tumor; Cohort Studies; Dihydrotestosterone; Furans; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, Nerve Growth Factor; Receptor, trkA; Receptor, trkC; Tosyl Compounds | 2007 |
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) associated with prostatic carcinoma.
Topics: Abdominal Pain; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Diagnosis, Differential; Fatal Outcome; Goserelin; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Nitriles; Paraneoplastic Syndromes; Prostatic Neoplasms; Tosyl Compounds; Weight Loss | 2000 |